Search Saint Luke's

Learn more about Saint Luke's Health System's awards and recognition.

Cardiometabolic

A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death in Participants with Increased Risk of Developing Heart Failure

Now starting his freshman year at Missouri Western University on a football scholarship, Jaylen Parks is grateful to Rockhill Orthopaedic Specialists for helping him get back on the field.

As a football quarterback, Montell Cozart was accustomed to calling the signals. But in the summer of 2023, he learned a lesson in listening to the signs his body was sending him.

Elizabeth Crow loves racing around the backyard with her 9-year-old daughter, Zakiyah. However, a little more than a year ago, that was impossible because of the 36-year-old's weight.

Sara McClure had been overweight for the majority of her life. “I was bullied a lot for the fact that I was a plus-size girl. I struggled with depression most of my life because of my obesity. Nothing changed as I became an adult — I was always the big girl.”

Seven months after a successful weight-loss surgery, Travis is down over 130 lbs and witnessing a complete life transformation beyond his expectations.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

Lung Cancer
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer

Becker's Hospital Review talked to Melinda L. Estes, MD, President and CEO of Saint Luke's Health System, and Richard Liekweg, President and CEO of BJC HealthCare, about the decision to join forces now.